Sotagliflozin Tablets 400 mg are an oral dual inhibitor of SGLT1 and SGLT2.
It inhibits glucose absorption in the intestine (SGLT1) and glucose reabsorption in the kidney (SGLT2), thereby lowering blood glucose through insulin‑independent pathways.
It also provides significant cardiorenal protection, particularly in patients with heart failure and chronic kidney disease.
Composition
Each film‑coated tablet contains:
Sotagliflozin …… 400 mg
Indications
Treatment of type 2 diabetes mellitus in adults to improve glycemic control.
Reduction of cardiovascular death and hospitalization for heart failure in adults with heart failure (HFrEF or HFpEF).
Renal protection in patients with chronic kidney disease associated with type 2 diabetes.
Key Features
Dual inhibition of SGLT1 and SGLT2
Improves both fasting and postprandial blood glucose
Proven cardiovascular and renal protective effects
Once‑daily oral administration
Low risk of hypoglycemia when used alone
Good safety and tolerability profile
Manufactured under strict GMP conditions
Complies with international pharmacopoeial standards
Complete registration dossiers available for global markets
Storage
Store in a cool, dry place, protected from light and moisture.
Keep out of reach of children.
Important Note
Prescription-only medicine.
Contraindicated in patients with hypersensitivity to sotagliflozin.
Monitor for hypotension, ketoacidosis, and genital mycotic infections.
Use with caution in renal impairment; adjust dose or discontinue as needed.
To be used under medical supervision.

Sulfadoxine-Pyrimethamine + Amodiaquine Tablets are a well-established Fixed-Dose Combination (FDC) antimalarial, designed for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum (including chloroquine-resistant strains) and Plasmodium vivax. By integrating three agents with distinct mechanisms of action, the tablets deliver rapid parasite clearance while minimizing the risk of developing drug resistance.
The formulation leverages the synergistic effects of:
Sulfadoxine: A sulfonamide antibiotic that blocks parasite folate synthesis by inhibiting dihydropteroate synthase (DHPS).
Pyrimethamine: A folic acid antagonist that targets dihydrofolate reductase (DHFR), disrupting the final step of folate metabolism.
Amodiaquine: A 4-aminoquinoline that interferes with parasite nucleic acid metabolism, killing the erythrocytic schizont stage directly.
This triple-action strategy ensures broad-spectrum efficacy and accelerates patient recovery, making it a preferred choice for malaria-endemic regions.
Indications
Treatment of acute uncomplicated malaria caused by P. falciparum (including multidrug-resistant strains) and P. vivax.
Prophylaxis (preventive use) in high-risk populations, under medical supervision.
Suitable for adults and children aged 2 years and above.
Key Features
Rapid Parasite Clearance: Dual folate pathway inhibition + nucleic acid disruption targets malaria parasites at multiple stages, ensuring fast resolution of symptoms.
High Resistance Coverage: Effective against strains resistant to single-agent antimalarials (e.g., chloroquine), reducing treatment failure rates.
Convenient Dosing: Single-dose or short 3-day course regimens improve patient compliance, especially for remote communities.
Quality Assured: Manufactured under strict GMP guidelines, compliant with USP/EP/CP pharmacopoeial standards. Complete regulatory documentation (DMF/COS) available for global market registration.
Stable Formulation: Optimized for storage in hot, humid malaria-endemic environments without compromising potency.
Dosage & Administration
For oral use only. Follow medical guidance.
Adults (≥18 years): Single oral dose (standardized by age/weight) or 3-day consecutive course (typical regimen: 1 tablet on Day 1, 1 tablet on Day 2/3, adjusted for severity).
Children (2–17 years): Weight-based dosage adjustment, administered under adult supervision.
Strictly avoid overdose; adhere to local treatment guidelines.
Storage
Store in a cool, dry place (15–25°C), protected from light, moisture, and heat. Keep out of reach of children.
Important Notes
Contraindications: Hypersensitivity to sulfonamides, quinoline derivatives, or any component of the formulation; severe hepatic/renal impairment; pregnant individuals (first trimester); lactating mothers.
Adverse Reactions: May include nausea, vomiting, rash, or headache. Discontinue and seek medical care if severe reactions (e.g., hepatic toxicity, hematological disorders) occur.
Drug Interactions: Avoid co-administration with other sulfonamide-containing medications or antifolates (e.g., trimethoprim).
Special Populations: Geriatric patients, children, and individuals with comorbidities (e.g., anemia, diabetes) require close monitoring during treatment.
This is a prescription medication. Use only under the guidance of a qualified healthcare provider.

Sulfadoxine‑Pyrimethamine + Dihydroartemisinin Tablets are an artemisinin‑based combination therapy (ACT) for the treatment of acute uncomplicated malaria.
This combination brings together:
Dihydroartemisinin: A fast‑acting artemisinin derivative that rapidly reduces parasite load and relieves clinical symptoms.
Sulfadoxine‑Pyrimethamine: A long‑acting antifolate combination that eliminates remaining parasites and prevents recrudescence.
The synergistic effect ensures high cure rates and helps delay the development of antimalarial drug resistance.
Indications
For the treatment of acute uncomplicated malaria caused by Plasmodium falciparum (including chloroquine‑resistant strains) and Plasmodium vivax in adults and children.
Key Features
Rapid parasite clearance and fast symptom relief
Long‑acting component improves cure rate and reduces relapse
Effective against many drug‑resistant malaria strains
Convenient oral tablet formulation
Good tolerability profile
Manufactured under GMP standards
Complies with international pharmacopoeial requirements
Full dossiers available for registration in malaria‑endemic countries
Storage
Store in a cool, dry place, protected from light and moisture.
Keep out of reach of children.
Important Note
Contraindicated in patients with hypersensitivity to any component
Use with caution in patients with hepatic or renal impairment
Not recommended in severe malaria
Should be used under medical supervision

Multivitamin Tablets with Vitamin C and Zinc are a comprehensive dietary supplement combining essential vitamins and minerals for daily health maintenance.
This formulation provides potent antioxidant support, promotes normal immune function, enhances energy metabolism, and helps maintain healthy skin, nerves, and cardiovascular function.
Composition per tablet
Niacin ………………………… 100 mg
Vitamin C ……………………… 750 mg
Vitamin B6 ……………………… 20 mg
Thiamine HCl ………………… 15 mg
Riboflavin ……………………… 15 mg
Calcium pantothenate ………… 32.6 mg
Folic acid ……………………… 490 μg
Vitamin B12 …………………… 12 μg
Vitamin E ……………………… 60 mg
Zinc …………………………… 22.50 mg
Indications
As a dietary supplement to prevent and correct vitamin and mineral deficiencies.
Support and strengthen immune system function.
Enhance antioxidant protection against oxidative stress.
Promote normal energy metabolism and reduce fatigue.
Support healthy nervous system function, skin health, and red blood cell formation.
Suitable for adults with increased nutritional requirements, stress, or irregular diet.
Key Features
Comprehensive formula with high‑potency vitamin C and zinc for immune support
Complete B‑complex for energy production and nervous system health
Added vitamin E for extra antioxidant action
Balanced and well‑tolerated once‑daily formulation
Suitable for long‑term daily use
Manufactured under strict GMP standards
Complies with international quality and pharmacopoeial requirements
Complete registration dossiers available for global markets
Storage
Store in a cool, dry place, protected from light and moisture.
Keep out of reach of children.
Important Note
This is a dietary supplement, not a replacement for a balanced diet.
Do not exceed the recommended daily dose.
If you are pregnant, breastfeeding, taking medication, or under medical supervision, consult a healthcare professional before use.
Discontinue use and seek medical advice if adverse reactions occur.

Tadalafil + Dapoxetine Tablets Kit is a fixed‑dose combination kit for the simultaneous treatment of male sexual dysfunction.
Tadalafil: A phosphodiesterase type 5 (PDE5) inhibitor that enhances blood flow to the corpus cavernosum, helping achieve and maintain erections sufficient for sexual activity.
Dapoxetine Hydrochloride: A short‑acting SSRI that improves ejaculatory control and prolongs intravaginal ejaculatory latency time.
This combination provides comprehensive improvement in both erection quality and ejaculatory control.
Indications
For the treatment of erectile dysfunction (ED) combined with premature ejaculation (PE) in adult men aged 18–64 years.
Key Features
Dual action: treats both ED and PE in one kit
Tadalafil: long duration of action, flexible dosing window
Dapoxetine: rapid onset, on‑demand use
Improved sexual confidence and satisfaction
Convenient oral administration
Good safety profile when used as directed
Manufactured under GMP standards
Complies with international pharmaceutical requirements
Storage
Store in a cool, dry place, protected from light and moisture.
Keep out of reach of children.
Important Note
This is a prescription‑only medicine.
Contraindicated in patients with hypersensitivity to tadalafil or dapoxetine.
Do not use with nitrates, severe cardiovascular disease, or severe hepatic/renal impairment.
May cause headache, dizziness, flushing, or nausea; avoid alcohol during use.
Use strictly under medical supervision.

Tadalafil Tablets 20mg are a selective phosphodiesterase type 5 (PDE5) inhibitor.
It works by relaxing blood vessels in the corpus cavernosum, increasing blood flow to achieve and maintain an erection sufficient for sexual intercourse, in response to sexual stimulation.
Composition
Each film‑coated tablet contains:
Tadalafil …… 20 mg
Indications
Treatment of erectile dysfunction (ED) in adult men.
Also used for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) in some regions.
Key Features
Long duration of action (up to 36 hours)
Rapid onset of effect
Effective even with mild to moderate ED
Can be taken with or without food
Good safety profile at recommended dose
Manufactured under GMP conditions
Complies with international pharmacopoeial standards
Complete registration dossiers available for global markets
Storage
Store in a cool, dry place, protected from light and moisture.
Keep out of reach of children.
Important Note
Prescription only medicine
Contraindicated in patients taking nitrates in any form
Contraindicated in severe cardiovascular disease, severe liver or kidney impairment
May cause headache, back pain, flushing, nasal congestion
Use under medical supervision only